Long term investing is the way to go, but that doesn't mean you should hold every stock forever. We really hate to ...

Pfizer has ended the global commercialisation of its haemophilia B (factor IX deficiency) gene therapy Beqvez, citing soft ...

AUBURN — It would’ve been understandable to experience déjà vu after the opening quarter of Friday’s Auburn and Williamsville Sangamo Conference boys basketball regular season finale game.

The Pleasant Plains boys basketball team picked up where it left off. Owen Johnson kicked things off with the open 3-pointer ...

Williamsville, Auburn, Pleasant Plains and Staunton will each appear in the Greenville Sectional beginning Tuesday and Wednesday. Lincoln and Chatham Glenwood, meanwhile, remain the last teams in the ...

Wells Fargo analyst Yanan Zhu maintained a Buy rating on Avidity Biosciences (RNA – Research Report) on February 28 and set a price target of ...

In a report released yesterday, Yanan Zhu from Wells Fargo maintained a Buy rating on uniQure (QURE – Research Report), with a price target of ...

DelveInsight's Advanced Therapy Medicinal Products Market Insights report provides the current and forecast market analysis, ...

Pfizer and Sangamo are hoping for a faster trajectory with their experimental treatment. The partners' one-shot giroctocogene fitelparvovec therapy has cleared a phase 3 trial, showing it was ...

The expansion of the advanced therapy medicinal products market is primarily fueled by the increasing incidence of chronic diseases. The rising prevalence of genetic disorders and cancer, along ...

C4 Therapeutics, Inc. (CCCC) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to loss of $0.68 per share a year ago. These ...